Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Fresenius Medical Care AG (FMCQF) over the last 17 years, with Q3 2025 value amounting to -$523.4 million.

  • Fresenius Medical Care AG's Net Cash Flow fell 26548.75% to -$523.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.3 million, marking a year-over-year increase of 4828.2%. This contributed to the annual value of -$286.6 million for FY2024, which is 21775.25% down from last year.
  • Per Fresenius Medical Care AG's latest filing, its Net Cash Flow stood at -$523.4 million for Q3 2025, which was down 26548.75% from $806.1 million recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Net Cash Flow registered a high of $806.1 million during Q2 2025, and its lowest value of -$523.4 million during Q3 2025.
  • In the last 5 years, Fresenius Medical Care AG's Net Cash Flow had a median value of -$63.1 million in 2021 and averaged $13.6 million.
  • Per our database at Business Quant, Fresenius Medical Care AG's Net Cash Flow plummeted by 116886.49% in 2024 and then surged by 112801.36% in 2025.
  • Fresenius Medical Care AG's Net Cash Flow (Quarter) stood at -$127.4 million in 2021, then soared by 304.4% to $260.3 million in 2022, then tumbled by 150.9% to -$132.5 million in 2023, then tumbled by 103.53% to -$269.7 million in 2024, then crashed by 94.07% to -$523.4 million in 2025.
  • Its last three reported values are -$523.4 million in Q3 2025, $806.1 million for Q2 2025, and -$88.4 million during Q1 2025.